Charles Schwab Investment Management Inc. Sells 23,043 Shares of Enovix Corporation $ENVX

Charles Schwab Investment Management Inc. reduced its stake in shares of Enovix Corporation (NASDAQ:ENVX) by 1.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,325,297 shares of the company’s stock after selling 23,043 shares during the period. Charles Schwab Investment Management Inc. owned 0.69% of Enovix worth $9,728,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Deutsche Bank AG increased its holdings in shares of Enovix by 44.8% during the 4th quarter. Deutsche Bank AG now owns 140,606 shares of the company’s stock worth $1,528,000 after purchasing an additional 43,498 shares during the period. Refined Wealth Management raised its position in Enovix by 18.8% in the 1st quarter. Refined Wealth Management now owns 675,449 shares of the company’s stock valued at $4,958,000 after purchasing an additional 106,843 shares during the last quarter. Strong Tower Advisory Services raised its holdings in shares of Enovix by 93.1% in the first quarter. Strong Tower Advisory Services now owns 144,045 shares of the company’s stock valued at $1,057,000 after buying an additional 69,435 shares during the last quarter. L & S Advisors Inc lifted its position in shares of Enovix by 50.6% during the first quarter. L & S Advisors Inc now owns 191,975 shares of the company’s stock worth $1,409,000 after purchasing an additional 64,471 shares in the last quarter. Finally, Register Financial Advisors LLC boosted its position in Enovix by 52.3% in the 1st quarter. Register Financial Advisors LLC now owns 266,336 shares of the company’s stock valued at $1,955,000 after buying an additional 91,486 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. TD Securities cut their price target on Enovix from $10.00 to $7.00 and set a “hold” rating on the stock in a research note on Thursday, May 1st. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $12.00 price target (up previously from $9.00) on shares of Enovix in a research note on Thursday, July 24th. Canaccord Genuity Group raised their target price on shares of Enovix from $20.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, August 4th. B. Riley restated a “buy” rating and set a $17.00 price objective (up from $12.00) on shares of Enovix in a research note on Thursday, July 10th. Finally, Cowen restated a “hold” rating on shares of Enovix in a report on Tuesday, July 8th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $17.00.

Enovix Trading Down 1.0%

ENVX opened at $10.41 on Tuesday. Enovix Corporation has a fifty-two week low of $5.27 and a fifty-two week high of $16.49. The company has a debt-to-equity ratio of 0.82, a current ratio of 4.37 and a quick ratio of 4.11. The firm has a market capitalization of $2.05 billion, a PE ratio of -12.39 and a beta of 2.11. The company’s 50-day moving average is $11.76 and its 200 day moving average is $9.25.

Enovix (NASDAQ:ENVX) last announced its earnings results on Thursday, July 31st. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. The firm had revenue of $7.50 million for the quarter, compared to the consensus estimate of $5.48 million. Enovix had a negative return on equity of 73.88% and a negative net margin of 481.35%.The company’s revenue was up 98.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.14) EPS. Enovix has set its Q3 2025 guidance at -0.180–0.140 EPS. As a group, research analysts predict that Enovix Corporation will post -1.01 earnings per share for the current fiscal year.

Enovix declared that its board has initiated a share repurchase plan on Wednesday, July 2nd that permits the company to repurchase $60.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Enovix Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.